PREVALENCE OF HEPATITIS C VIRUS AMONG PATIENTS ATTENDING STATE SPECIALIST HOSPITAL MAIDUGURI, NIGERIA

Mustafa Alhaji Isa

Abstract


Hepatitis C virus is among the most common cause of viral hepatitis which considered as a major public health problem worldwide. This study was aimed to determine the prevalence of hepatitis C (HCV) antibody among patients attending State Specialist Hospital Maiduguri using test kits(Manufactured by NEB CO., LTD), after the patients were advised on the need to know their status. Out of one hundred serum samples, only 6(6.0%) were positive. This includes, 2 (4.3%) were male while 4 (7.5%) were female. Distribution of HCV based age showed that those between 11- 20 years had higher prevalence of 13.6%, followed by >40 years 8.3%, 31- 40years 3.7% and 21- 30years have 2.7%. However, zero prevalence was recorded among <1- 10years group. Also HCV based on educational status showed that, only 4(5.5%) positive was found among people that attained formal education out of 73 samples tested while 2(7.4%) positive was found amongst people that attained non-formal education out of 27 samples tested. Therefore, there is urgent need to take public health measures to reduce disease burden and transmission, by routine screening of all for HCV infections and also government should provide health education campaigns to people on the dangers associated with HCV infection.

Keywords


Prevalence, HCV, Patients and Hospital

Full Text:

PDF

References


Ayolabi, C. I., Taiwo, A. M., Omilabu, S. A. Abebisi, O. A. And Fatoba, M. O. (2006). Seroprevalence of Hepatitis C virus among Blood Donors in Lagos, Nigeria. African J. Biotechnol., 5(20): 1944-1946.

Memon M. I. Memon M. A. (2002). Hepatitis C: an epidemiological review J. Viral Hepat. 9:84-100.

Ashraf H., Alam H. N. Rothermundr C., Brooks A., Bardhan P., Hossain L., Salam A. M., Hassan S. M., Beglinger C. And Gyr N. (2010). Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infectious Diseases. 10:208. http://biomedcentral.com/1471-2334/10/208

Bonkovsky H. L. And Mehta S. (2001) Hepatitis C. A review and updates. J Am Acad Dermatol 44:159-79.

Chen, L., Liu F., Fan X., Gao J., Chen N., Wong T., Wu J., Wen S. W. (2009). Detection of hepatitis B surface antigen, hepatitis B core antigen and hepatitis B virus DNA in parotid tissues. International Journal of Infectious Diseases. 13: 20-23.

Choudhary I. A., Khan S. A. And Samiullah (2005). Should we do hepatitis B and C screening on each patient before surgery. Pak J Med Sci. 21:278-80.

Ebie, J. C. and Pela, O. A. (2006). Some sociocultural aspects of the problem of drug abuse in

Nieria. Drug and Alc. Dep. 8: 301-306.

Ejele, O. A., Nwauche, C. A. and Erhabor, O. (2006). Seroprevalence of Hepatitis C Virus in Niger Delta of Nigeria. The Nigerian Postgraduate Medical J., 13(2): 103- 106.

Frank C., Mohamed M. K., Strickland G. T., Lavanchy D., Arthur R. R., Magder L. S., El Khoby T., Abdel-Wahab Y., Aly Ohn E. S., Anwar W. and Sallam I. (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 355:887-91.

Halim, N. K. D. and Ajayi, I. O. (2000). Risk factors and Seroprevalence of Hepatitis C antibody in Blood Donors in Nigeria. East African Medical j., 77(8): 410-412.

Hayashmi J., Kishiharar Y., Yamaji K., Yoshimura E., Kawakami Y., Akazawa K., et al. (1995). Transmission of hepatitis C virus by Health care workers in a rural area of Japan. Am Jm Gastroenterol.

Inyama, P. U., Uneke, J. C., Anyanwu, I. G., Njoku, M. O., Idoko, J. H. and Idoko, A. J. (2005). Prevalence of Antibodies to Hepatitis C virus among Nigerian patients with HIV infections. Online J. Health and Allied Sciences. 2:2. Available at www. Ojhas.org/issue 14/2005-2-2.htm.

Mustapha S. K., Bolori M. T., Ajayi NA, Aggada HA, Pindiga UH, Gashau W, Khalil MIA. (2007). Hepatocellular carcinoma in north- Eastern Nigeria: A prospective Clinical Study of 100 cases. The Internet Journal of Gastroenterology; 6(1).

National Population Commission, Nigeria. (2006). Report of the final national census results.

Abuja.

Pennap G. R., Yakubu A., Oyige O., Forbi J. (2010). Prevalence of hepatitis B and C virus infection among people of a local community in Keffi, Nigeria. African Journal of Microbiology Research 4 (4): 274-278.

Polyak P. (2006). Innate intracellular defence against HIV and its modulation by HCV gene product. Postgraduate Course, Vienna pp. 30-33.

Schiff E. (2002). Hepatitis Central, Current information on Hepatitis C and treatment for medical profession, Uni Miami; 1-2.

Strickland, G. T. (2002). HCV in developing Countries.Postgrad. Doc. (Africa) 24: 18-20.

Sule W. F., Odama L. E., Daniel A. L.., Faneye A. O. and Okonko I. O. (2009). Prevalence of Anti- Hepatitis C Virus in patients attending Federal Medical Centre (FMC), Lokoja, Kogi State, Nigeria. World Applied Sciences Journal 7(3): 371- 377.

Tess, B. H., Levin, A., Brubaker, G. Shao, J., Drummond, E. J., Alter, J. H. and Brien, O. R. T. (2000). Seroprevalence of Hepatitis C Virus in the General population of Northwest Tanzania. American J. Tropical Medicine and Hygiene, 62(1): 138- 141.

Ugbebor O., Aigbirior M., Osazuwa F., Ehigha E. and Zabayo O. (2011). The prevalence of hepatitis B and C viral infections among pregnant women. North American Journal of Medical Sciences, Volume 3. No. 5.

World Health Organisation (2007). Hepatitis C, estimated prevalence and number infected by world region. Available at http :// www . who .int / csr / disease /hepatitis


Refbacks

  • There are currently no refbacks.


Copyright (c) 2014 The Journal of Applied Sciences Research

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.